Autologous cell-based therapy for treatment of large bone defects: from bench to bedside.

ABSTRACT: OBJECTIVES:Reconstruction of long segmental bone defects is demanding for patients and surgeons, and associated with long-term treatment periods and substantial complication rates in addition to high costs. While defects up to 4-5 cm length might be filled up with autologous bone graft, heterologous bone from cadavers, or artificial bone graft substitutes, current options to reconstruct bone defects greater than 5 cm consist of either vascularized free bone transfers, the Masquelet technique or the Ilizarov distraction osteogenesis. Alternatively, autologous cell transplantation is an encouraging treatment option for large bone defects as it eliminates problems such as limited autologous bone availability, allogenic bone immunogenicity, and donor-site morbidity, and might be used for stabi

SUBMITTER: Verboket R 

PROVIDER: S-EPMC6182650 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature